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Abstract: 26
Zika virus (ZIKV) recently emerged in the Western Hemisphere with previously unrecognized or 27
unreported clinical presentations. Here, we identify two distinct binding mechanisms of ancestral and 28 emergent ZIKV strains featuring the envelope (E) protein residue ASN154 and viral phosphatidylserine 29 (PS). Short (20-mer) peptides representing the region containing ASN154 from strains PRVABC59 (Puerto 30
Rico 2015) and MR_766 (Uganda 1947) were exposed to neuronal cells and fibroblasts, expecting 31
interactions to be representative of ZIKV E protein/cell interactions, and bound MDCK or Vero cells and 32 primary neurons significantly above a scrambled PRVABC59 control peptide. Peptides also significantly 33 inhibited Vero cell adsorption by ZIKV strains MR_766 and PRVABC59, indicating that we have identified 34 a binding mechanism of ancestral African ZIKV strains and emergent Western Hemisphere strains. 35 Pretreatment of ZIKV MR_766 and PRVABC59 with the PS-binding protein annexin V significantly 36 inhibited replication of PRVABC59, but not MR_766, suggesting that Western hemisphere strains are 37 additionally utilizing PS-mediated entry to infect host cells. Taken together, these data indicate that we 38
have identified an ancestral binding mechanism of ZIKV, and a secondary binding mechanism utilized by 39
Western Hemisphere strains. 40 41 Background 42
Zika virus (ZIKV) is a mosquito-borne Flavivirus that recently emerged and established 43 endemicity in the Western Hemisphere (reviewed here 1-2 ). ZIKV disease historically presented as a mild 44 febrile illness featuring myalgia, rash, and conjunctivitis; however, novel and more severe clinical 45 presentations and increased disease incidence were reported as the virus emerged in the South Pacific 3-4 46 and the Western Hemisphere 5-7 . Since that time, case reports and animal models have implicated ZIKV in 47 a congenital syndrome most notably featuring microcephaly 7-12 , primary encephalitis, encephalomyelitis, 48 lyssencephaly, or Guillan-Barré syndrome 5, 13-20 , chorioamnionitis 21 , testicular infection 22 , changes in 49 semen quality 23 , and potentially a hemorrhagic shock syndrome 24-25 . The biology and pathogenesis of 50 ZIKV were virtually unexplored at the time of its detection in the Western Hemisphere, making rapid 51 progress toward diagnostics, therapeutics, or vaccine development challenging in the absence of 52 targets 26 . 53 Substantial progress in the understanding of ZIKV biology has been made in a short time, and 54 includes identification of divergent nucleotide and amino acid sites 27-30 , potential host cell ligands 31-33 , 55 factors that impact replication kinetics 34-37 , and the development of animals models for both 56 neurological and prenatal disease [38] [39] explain the newly emerged ability to directly invade the central nervous system (CNS). We sought to 61 build upon our recent informatics analysis 27 by utilizing the findings to identify the binding mechanism of 62 ZIKV. We hypothesized that NAG-glycosylation of E protein ASN154 is linked to ZIKV neuroinvasiveness 63 and that this region plays a critical role in host cell adsorption across strains. 64
Results and Discussion 65

Binding Motif Prediction 66
Structural modeling predictions of strain PRVABC59 (Puerto Rico, 2015) indicated that ASN154 is 67 part of a linear β strand (Fig.1A) . The disorder probability of this region peaks at 0.72 ( Fig.1B ), suggesting 68 that this portion of the E protein is particularly dynamic and flexible. Structural and disorder probability 69 predictions of the African type strain MR_766 (Uganda 1947) and the Nigerian strain IbH30656 (Nigeria, 70 1968) exhibit similar characteristics (Fig.1C (NAGylated and unglycosylated) controls ( Fig. 2A , supplemental Fig. S1 ), suggesting that this motif has 81 the potential to serve as a ZIKV receptor. Binding of the MR_766 ZVBM peptides, despite a four-amino 82 acid deletion relative to PRVABC59, suggests that the critical portion of the ZVBM is potentially 83 contained entirely on the aminoterminus (NTD) or the carboxyterminus (CTD). A peptide representing 84 the NTD of PRVABC59 was unable to bind Vero cells above scrambled control, whereas a peptide 85
representing the CTD bound significantly (P<0.05) above the scrambled control, indicating that the 86 putative receptor is contained entirely on the CTD of ZVBM ( Fig. 2B ). Pretreatment of Vero cell 87 monolayers with the unglycosylated ("Africanized") PRVABC59 ZVBM significantly (P<0.01) inhibited 88 infectivity of ZIKV MR_766; conversely, pretreatment of Vero cells with the NAGylated (native) 89
PRVABC59 ZVBM significantly (P<0.05) inhibited infectivity of ZIKV PRVABC59 (Fig. 2C , Supplemental  90  Table S1 ). These findings demonstrate that adherence of ZVBM peptides to Vero cells has functional 91 relevance, and that this motif mediates at least some host cell adsorption. 92 Unglycosylated ZVBM peptides from MR_766 and PRVABC59 bound Madin-Darby Canine Kidney 93 (MDCK) cells significantly (P<0.05) above (unglycosylated) scrambled control. Interestingly, NAGylated 94 PRVABC59 did not bind MDCK cells above the NAGylated scrambled control, indicating that functionality 95 of ZVBM as a receptor is host cell-specific ( Fig. 2D ). Given that MDCK cells are still permissive for ZIKV 96 replication 40 , we hypothesized that a more generalized receptor may be contributing to viral adsorption 97 when ZVBM is NAGylated. The association of human AXL with ZIKV adsorption 31-33 suggests that viral 98 phosphatidyl serine (PS) may facilitate entry into certain host cells by binding Gas6, which in turn binds 99 AXL, as is seen with multiple viruses 41-45 . We pretreated ZIKV strains MR_766 and PRVABC59 with the 100 PS-binding protein Annexin V prior to infection of Vero cell monolayers. Annexin V significantly (P<0.05) 101
inhibited infectivity of PRVABC59 relative to untreated controls (51% reduction) but did not inhibit 102 MR_766 ( Fig.2E , Supplemental Table S1 ), indicating that PS-mediated ZIKV adsorption is possible for 103 ZVBM-NAGylated (i.e., Asian and American lineage) strains. While at least one additional mechanism 104 has been described for the greater infectivity of Asian and American strains 37 , PS-mediated host cell 105 entry is likely to contribute to this phenotype as well. The capacity of Asian and American lineage strains 106
to utilize at least two binding mechanisms (i.e., PS and ZVBM) suitably explains how AXL can serve as a 107
host cell receptor, but animals who have undergone genetic ablation for axl can still serve as permissive 108
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